Abstract

Deep Brain Stimulation (DBS) is an invasive device-based neuromodulation technique that allows the therapeutic direct stimulation of subcortical and deep cortical structures following the surgical placement of stimulating electrodes. DBS is approved by the U.S. Federal Drug Administration for the treatment of movement disorders and obsessive-compulsive disorder, while new indications, including Major Depressive Disorder (MDD), are in experimental development. We report the case of a patient with MDD who received DBS to the ventral internal capsule and ventral striatum bilaterally and presented with 2 weeks of voltage-dependent Tourette-like symptoms including brief transient episodes of abrupt-onset and progressively louder coprolalia and stuttered speech; tic-like motor behavior in his right arm and leg; rushes of anxiety, angry prosody, angry affect; and moderate amnesia without confusion. We describe the results of the inpatient neuropsychiatric workup leading to the diagnosis of iatrogenic voltage-dependent activation of cortico-subcortical circuits and discuss insights into the pathophysiology of Tourette as well as safety considerations raised by the case.

Highlights

  • Deep Brain Stimulation (DBS) is an invasive neuromodulation technique that allows the direct stimulation of subcortical and deep cortical structures following the surgical placement of brain electrodes connected to an implantable battery-powered pulse generator

  • DBS is approved by the U.S Federal Drug Administration (FDA) for the treatment of patients with severe and refractory movement disorders or Obsessive-Compulsive Disorder (OCD)

  • DBS stimulation with the iatrogenic montage (0 + 1−) compared to stimulation with the monopolar configuration at contact 3 led to a significant increase in perfusion in the insula, pallidum, and the anterior cingulate

Read more

Summary

Introduction

Deep Brain Stimulation (DBS) is an invasive neuromodulation technique that allows the direct stimulation of subcortical and deep cortical structures following the surgical placement of brain electrodes connected to an implantable battery-powered pulse generator. It aims to act as a neural pacemaker, improving function in diseased neuronal populations, and facilitating therapeutic adaptive changes in brain networks. Several experimental approaches are exploring the use of DBS for other treatment-resistant neuropsychiatric disorders, including Major Depressive Disorder (MDD; Kaur et al, 2013), Gilles de la Tourette Syndrome (GTS; Andrade and Visser-Vandewalle, 2016), and others (Arulpragasam et al, 2013)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call